Skip to main content

Table 2 NKG2D-expressing NK and T cells

From: Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions

 

Percentage of NKG2D-expressing cells

Subjects

CD56 + CD3 -

CD56 - CD3 +

 

Mean

± SD

Min

Max

p

Mean

± SD

Min

Max

p

Healthy

50.40 ±

20.78

21.44

83.84

 

24.80 ±

7.67

17.30

40.20

 

LSIL

28.57 ±

1.36

3.60

78.40

0.010

15.74 ±

6.91

6.40

28.50

0.041

HSIL

40.90 ±

5.67

2.70

88.10

0.495

12.20 ±

7.49

2.40

22.80

0.011

Invasive carcinoma

27.49 ±

9.62

0.50

82.90

0.034

8.28 ±

0.25

0.10

29.60

0.005

  1. p represents the value obtained of comparing LSIL, HSIL, and carcinoma subjects vs healthy subjects